Table 2. Associations of GGT/HDL-C ratio with prevalence of NAFLD/MS by univariate regression analyses.
| Characteristics | NAFLD | MS | |||
|---|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | ||
| Sex (male) | 3.181 (2.829–3.577) | <0.001 | 2.165 (1.929–2.428) | <0.001 | |
| Age | 1.025 (1.020–1.031) | <0.001 | 1.042 (1.036–1.048) | <0.001 | |
| WC | 1.195 (1.183–1.207) | <0.001 | 1.177 (1.166–1.189) | <0.001 | |
| BMI | 1.633 (1.589–1.679) | <0.001 | 1.505 (1.468–1.543) | <0.001 | |
| SBP | 1.034 (1.031–1.037) | <0.001 | 1.050 (1.046–1.053) | <0.001 | |
| DBP | 1.061 (1.056–1.067) | <0.001 | 1.080 (1.074–1.086) | <0.001 | |
| ALP | 1.013 (1.011–1.016) | <0.001 | 1.018 (1.015–1.021) | <0.001 | |
| ALT | 1.047 (1.043–1.051) | <0.001 | 1.025 (1.022–1.029) | <0.001 | |
| AST | 1.042 (1.036–1.049) | <0.001 | 1.024 (1.018–1.030) | <0.001 | |
| Cr | 1.026 (1.022–1.030) | <0.001 | 1.018 (1.014–1.022) | <0.001 | |
| TC | 1.381 (1.299–1.469) | <0.001 | 1.233 (1.160–1.312) | <0.001 | |
| TG | 2.333 (2.177–2.500) | <0.001 | 5.970 (5.379–6.625) | <0.001 | |
| LDL-C | 1.389 (1.293–1.492) | <0.001 | 1.069 (0.994–1.149) | 0.072 | |
| UA | 1.010 (1.009–1.011) | <0.001 | 1.007 (1.006–1.008) | <0.001 | |
| HOMA-IR | 2.386 (2.255–2.526) | <0.001 | 2.259 (2.138–2.387) | <0.001 | |
| Smoke (%) | 1.864 (1.617–2.149) | <0.001 | 1.816 (1.572–2.097) | <0.001 | |
| GGT/HDL-C | 1.036 (1.033–1.039) | <0.001 | 1.035 (1.032–1.038) | <0.001 | |
NAFLD, nonalcoholic fatty liver disease; MS, metabolic syndrome; OR, odds ratio; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; WC, waist circumstance; MS, metabolic syndrome; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; TG, triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; Cr, creatinine; UA, uric acid; HOMA-IR, homeostasis model assessment of insulin resistance; GGT/HDL-C, GGT/HDL-C ratio.